Actualiteit

The team formed by doctors Belen Lledo, Jose Antonio Ortiz and Rafael Bernabeu have carried out an analysis on the epigenetic profile of women with low ovarian reserve which has just been published in the scientific journal of the American Society for Reproductive Medicine (ASRM) , Fertility and Sterility.

Continuous research and the desire to improve the prognosis of those who trust the Instituto Bernabeu has allowed the clinic to develop the most complete genetic study of premature ovarian failure (POF).

 We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". IBgen POF, the new ovarian failure genetic study

Period aches are not normal and it’s necessary to check what is going on. This is how Dr Belen Moliner, the international specialist and head of the pioneering Endometriosis Unit of Instituto Bernabeu, starts.

 We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Publication on new studies about ovarian stimulation

March the 8th defends women’s role in the 21st century society. Instituto Bernabeu, which was created for and to women, has gather a female representation of our human team to thank all those women who opened the equality path, also those who are present now and to all of those who will come later.

The Instituto Bernabeu professionals add to their vocation for assistance, being teachers and researchers. Many of the clinic's professionals contribute with their experience as professors at Universities and Masters.

The specialized journal Systems Biology in Reproductive Medicine has published in its January issue an Instituto Bernabeu investigation on the effect of ovarian stimulation on the embryo’s chromosomal endowment.

Reproductive medicine development is achieved with a multidisciplinary perspective. Advances that arise by leaps and bounds and that allow us to offer better and more successful treatments. At Instituto Bernabeu, the care vocation is accompanied by an important research effort and, in turn, a work to disseminate current evidence that can improve treatments.

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". 2020: A year where we never stopped investigating.